SE467925B - 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma - Google Patents

8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma

Info

Publication number
SE467925B
SE467925B SE8802323A SE8802323A SE467925B SE 467925 B SE467925 B SE 467925B SE 8802323 A SE8802323 A SE 8802323A SE 8802323 A SE8802323 A SE 8802323A SE 467925 B SE467925 B SE 467925B
Authority
SE
Sweden
Prior art keywords
compound
formula
acid addition
addition salt
pharmaceutically acceptable
Prior art date
Application number
SE8802323A
Other languages
English (en)
Swedish (sv)
Other versions
SE8802323L (sv
SE8802323D0 (sv
Inventor
W Haefliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8802323D0 publication Critical patent/SE8802323D0/xx
Publication of SE8802323L publication Critical patent/SE8802323L/xx
Publication of SE467925B publication Critical patent/SE467925B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
SE8802323A 1987-06-23 1988-06-21 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma SE467925B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23

Publications (3)

Publication Number Publication Date
SE8802323D0 SE8802323D0 (sv) 1988-06-21
SE8802323L SE8802323L (sv) 1988-12-24
SE467925B true SE467925B (sv) 1992-10-05

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802323A SE467925B (sv) 1987-06-23 1988-06-21 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma

Country Status (28)

Country Link
US (1) US5075318A (fi)
JP (1) JPH0670052B2 (fi)
KR (1) KR970001527B1 (fi)
AT (1) AT395242B (fi)
AU (1) AU615657B2 (fi)
BE (1) BE1004034A3 (fi)
CA (1) CA1302404C (fi)
CH (1) CH674646A5 (fi)
CY (1) CY1752A (fi)
DK (1) DK169335B1 (fi)
ES (1) ES2010282A6 (fi)
FI (1) FI88302C (fi)
FR (1) FR2617166B1 (fi)
GB (1) GB2206115B (fi)
GR (1) GR1002318B (fi)
HK (1) HK2794A (fi)
HU (2) HU203097B (fi)
IE (1) IE60550B1 (fi)
IL (1) IL86820A (fi)
IT (1) IT1219652B (fi)
LU (1) LU87251A1 (fi)
MY (1) MY103584A (fi)
NL (1) NL8801597A (fi)
NZ (1) NZ225112A (fi)
PH (1) PH24690A (fi)
PT (1) PT87781B (fi)
SE (1) SE467925B (fi)
ZA (1) ZA884505B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.

Also Published As

Publication number Publication date
HU203097B (en) 1991-05-28
HU211651A9 (en) 1995-12-28
IL86820A (en) 1991-07-18
FI88302C (fi) 1993-04-26
FR2617166A1 (fr) 1988-12-30
CA1302404C (en) 1992-06-02
CY1752A (en) 1994-06-03
DK340188D0 (da) 1988-06-21
ZA884505B (en) 1990-02-28
IL86820A0 (en) 1988-11-30
MY103584A (en) 1993-08-28
GR880100401A (el) 1989-03-08
FR2617166B1 (fr) 1992-07-17
US5075318A (en) 1991-12-24
IE881867L (en) 1988-12-23
FI883008A0 (fi) 1988-06-22
DK169335B1 (da) 1994-10-10
PT87781B (pt) 1992-10-30
BE1004034A3 (fr) 1992-09-15
KR890000479A (ko) 1989-03-14
KR970001527B1 (ko) 1997-02-11
SE8802323L (sv) 1988-12-24
ES2010282A6 (es) 1989-11-01
GR1002318B (el) 1996-05-13
HUT50174A (en) 1989-12-28
IE60550B1 (en) 1994-07-27
IT8848097A0 (it) 1988-06-17
JPS6422876A (en) 1989-01-25
IT1219652B (it) 1990-05-24
SE8802323D0 (sv) 1988-06-21
FI883008A (fi) 1988-12-24
NL8801597A (nl) 1989-01-16
AT395242B (de) 1992-10-27
HK2794A (en) 1994-01-21
DK340188A (da) 1988-12-24
LU87251A1 (fr) 1989-03-08
GB2206115A (en) 1988-12-29
GB8814615D0 (en) 1988-07-27
PH24690A (en) 1990-09-07
GB2206115B (en) 1991-04-03
FI88302B (fi) 1993-01-15
JPH0670052B2 (ja) 1994-09-07
AU1819488A (en) 1989-01-05
PT87781A (pt) 1989-05-31
AU615657B2 (en) 1991-10-10
NZ225112A (en) 1991-03-26
CH674646A5 (fi) 1990-06-29
ATA161788A (de) 1992-03-15

Similar Documents

Publication Publication Date Title
FI86424B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva piperidinfoereningar.
KR100247121B1 (ko) 헤테로시클릭 화합물과 그의 제조방법 및 용도
HU211575A9 (en) 2-methyl-thieno-benzodiazepine
JPH0686449B2 (ja) 新規キヌクリジン類、該化合物を含有する医薬組成物、及びその製造方法
PT100854A (pt) Produtos farmaceuticos em especial derivados de quinolizidina ou de indolizidina, e processo para a sua preparacao e utilizacao
JPH0764821B2 (ja) ベンゾアゼピン誘導体
SE467925B (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
NO301227B1 (no) Arylsubstituerte, heterosykliske forbindelser, anvendelser derav og farmasöytisk preparat som omfatter en slik forbindelse
NO301164B1 (no) Alkylsubstituerte, heterosykliske forbindelser, anvendelser derav og farmasöytisk preparat som omfatter en slik forbindelse
NO309090B1 (no) Nye indolforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
DE69211857T2 (de) 3-(N-ISOPROPYL-N-u-PROPYLAMINO)-5-(N-ISOPROPYL)CARBAMOYLCHROMAN
HUT61301A (en) Process for producing condensed diazepinone derivatives and pharmaceutical compositions comprising same as active ingredient
CS204036B2 (en) Method of producing novel 4-phenyl-thieno/2,3-c/piperid
HU195491B (en) Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
SU1083908A3 (ru) Способ получени производных 2-(4-оксиалкил-1-пиперазинил)-2,4,6-циклогептатриен-1-она
EP1129097A1 (en) Novel type condensed pyridazinone compounds
WO1998031679A1 (fr) Composes de thiophene et leur application medicinale
DE3820159A1 (de) 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
HUT70856A (en) 4-thoxo-thiazolidin-2-ylidene-thiosemicarbazone derivatives, process for preparing them and pharmaceutical compositions containing them
KR20030030817A (ko) 세로토닌 운반 억제제
PL157529B1 (en) Method for manufacturing 8 alfa-acyloaminergoline
PT87461B (pt) Processo para a preparacao de 1-{n-(2-alquiltio-10h-fenotiazin-10-il)alquil}-4-benzoilpiperidinas e de composicoes farmaceuticas que os contem
CZ77898A3 (cs) Kyselé adiční soli 2,3,4,5-tetrahydro-1H-3-benzazepinových sloučenin
JPH0320396B2 (fi)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8802323-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8802323-9

Format of ref document f/p: F